Detalhe da pesquisa
1.
Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
Cancer Sci
; 103(2): 342-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22050138
2.
Bevacizumab improves the delivery and efficacy of paclitaxel.
Anticancer Drugs
; 21(7): 687-94, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20559127
3.
Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans--toxicological implications.
J Toxicol Sci
; 36(4): 411-22, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21804305
4.
Bridging from preclinical to clinical studies for tyrosine kinase inhibitors based on pharmacokinetics/pharmacodynamics and toxicokinetics/toxicodynamics.
Drug Metab Pharmacokinet
; 26(6): 612-20, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21897052